Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients

被引:36
作者
Wang, Guoqin [1 ]
Sun, Lijun [1 ]
Dong, Hongrui [1 ]
Wang, Yanyan [1 ]
Xu, Xiaoyi [1 ]
Zhao, Zhirui [1 ]
Cheng, Wenrong [1 ]
Liu, Xuejiao [1 ]
Zhao, Xiaoyi [2 ]
Geng, Yanqiu [3 ]
Bao, Siqin [4 ]
Chen, Yipu [1 ]
Cheng, Hong [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Div Nephrol, 2 Anzhen Rd, Beijing 100029, Peoples R China
[2] Chifeng Univ, Div Nephrol, Affiliated Hosp, Neimenggu, Peoples R China
[3] Third Med Ctr Chinese Peoples Liberat Army Gen Ho, Div Nephrol, Beijing, Peoples R China
[4] Peoples Hosp Xinganmeng, Div Nephrol, Neimenggu, Peoples R China
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 16卷 / 05期
关键词
membranous nephropathy; neural epidermal growth factor-like 1 protein; phospholipaseA2; receptor; thrombospondintype; 1; domain-containing7A; DOMAIN-CONTAINING; 7A; ANTIBODIES; GLOMERULONEPHRITIS; AUTOANTIBODIES; RECEPTOR; NELL-1; LUPUS;
D O I
10.2215/CJN.11860720
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The neural EGF-like 1 (NELL-1) protein is a novel antigen in primary membranous nephropathy. The prevalence and clinical characteristics of NELL-1-positive membranous nephropathy in Chinese individuals with primary membranous nephropathy are unclear. Design, setting, participants, & measurements A total of 832 consecutive patients with biopsy-proven primary membranous nephropathy were enrolled. The glomerular expression of phospholipase A2 receptor (PLA2R) and thrombospondin type 1 domain-containing 7A (THSD7A) was screened. Glomerular immunohistochemistry staining for NELL-1 was performed in 43 patients with PLA2R- and THSD7A-negative membranous nephropathy, 31 patients with PLA2R-positive membranous nephropathy, and two patients with PLA2R and THSD7A double positivity. The NELL-1 antibody was also detected in the sera of patients with NELL-1-positive membranous nephropathy by western blot. Clinical and pathologic features were comparable between patients with isolated NELL-1-positive, isolated PLA2R/THSD7A-positive, and triple antigen-negative membranous nephropathy. Results Among the 832 patients with primary membranous nephropathy, 11 of 54 (20%) patients with PLA2R-negative membranous nephropathy had THSD7A-positive membranous nephropathy. NELL-1-positive membranous nephropathy accounted for 35% (15 of 43) of all patients with PLA2R- and THSD7A-negative membranous nephropathy. One patient was double positive for NELL-1 and PLA2R in glomerular deposits and positive for only the PLA2R antibody in the serum. Most patients with NELL-1-positive membranous nephropathy were women. No tumors were found. There were significant differences in the prevalence of IgG subtypes between patients with different antigen positivity. Among patients with isolated NELL-1-positive membranous nephropathy, although80%(12 of 15) were IgG4 staining positive, the proportion of IgG4dominance was only 67% (ten of 15). Conclusions About one third of patients whowere PLA2R and THSD7A negative were NELL-1 positive in Chinese patients with primary membranous nephropathy. NELL-1-positive membranous nephropathy was more common than THSD7A-positive membranous nephropathy in PLA2R-negative membranous nephropathy.
引用
收藏
页码:727 / 735
页数:9
相关论文
共 27 条
[1]   Antigens, antibodies, and membranous nephropathy: a decade of progress [J].
Ahmad, Syeda Behjat ;
Appel, Gerald B. .
KIDNEY INTERNATIONAL, 2020, 97 (01) :29-31
[2]   M-Type Phospholipase A(sub 2) Receptor as Target Antigen in Idiopathic Membranous Nephropathy. [J].
Beck, Laurence H., Jr. ;
Bonegio, Ramon G. B. ;
Lambeau, Gerard ;
Beck, David M. ;
Powell, David W. ;
Cummins, Timothy D. ;
Klein, Jon B. ;
Salant, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (01) :11-21
[3]   Membranous Nephropathy: Approaches to Treatment [J].
Bomback, Andrew S. ;
Fervenza, Fernando C. .
AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 :30-42
[4]   Primary Membranous Nephropathy [J].
Couser, William G. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (06) :983-997
[5]   Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy [J].
Dong, Hong-rui ;
Wang, Yan-yan ;
Cheng, Xiao-hong ;
Wang, Guo-qing ;
Sun, Li-jun ;
Cheng, Hong ;
Chen, Yi-pu .
PLOS ONE, 2016, 11 (05)
[6]   Efficient Production and Characterization of Recombinant Human NELL1 Protein in Human Embryonic Kidney 293-F Cells [J].
Hasebe, Ai ;
Tashima, Hiroki ;
Ide, Teruhiko ;
Iijima, Masumi ;
Yoshimoto, Nobuo ;
Ting, Kang ;
Kuroda, Shun'ichi ;
Niimi, Tomoaki .
MOLECULAR BIOTECHNOLOGY, 2012, 51 (01) :58-66
[7]   An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy [J].
Hoxha, Elion ;
Beck, Laurence H., Jr. ;
Wiech, Thorsten ;
Tomas, Nicola M. ;
Probst, Christian ;
Mindorf, Swantje ;
Meyer-Schwesinger, Catherine ;
Zahner, Gunther ;
Stahl, Phillip R. ;
Schoepper, Ruth ;
Panzer, Ulf ;
Harendza, Sigrid ;
Helmchen, Udo ;
Salant, David J. ;
Stahl, Rolf A. K. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 28 (02) :520-531
[8]   A Mechanism for Cancer-Associated Membranous Nephropathy [J].
Hoxha, Elion ;
Wiech, Thorsten ;
Stahl, Rolf A. K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (20) :1995-1996
[9]   IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression [J].
Huang, Cheng Cheng ;
Lehman, Amy ;
Albawardi, Alia ;
Satoskar, Anjali ;
Brodsky, Sergey ;
Nadasdy, Gyongyi ;
Hebert, Lee ;
Rovin, Brad ;
Nadasdy, Tibor .
MODERN PATHOLOGY, 2013, 26 (06) :799-805
[10]   IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis [J].
Imai, H ;
Hamai, K ;
Komatsuda, A ;
Ohtani, H ;
Miura, AB .
KIDNEY INTERNATIONAL, 1997, 51 (01) :270-276